Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 33

1.

Impact of pharmaceutical industry involvement in the external review of clinical practice guidelines-A case study.

Bartelmann K, Gaskins M, Dressler C, Nast A.

J Eval Clin Pract. 2019 May 16. doi: 10.1111/jep.13166. [Epub ahead of print]

PMID:
31095829
2.
3.

Hidden treasures: exploring selective publication of trials and trial outcomes in biological treatment for plaque psoriasis.

Mashayekhi S, Nast A, Gaskins M, Ahmed S, Turner EH, Flohr C.

Br J Dermatol. 2019 Feb 13. doi: 10.1111/bjd.17773. [Epub ahead of print] No abstract available.

PMID:
30756373
4.
5.

Prioritizing topics in guideline development: results of a two-phase online survey of dermatologist members of the EADV.

Nast A, Gaskins M, Eisert L, Werner RN, Borradori L, Marinovic B, Paul C, Dressler C.

J Eur Acad Dermatol Venereol. 2019 Jan;33(1):227-233. doi: 10.1111/jdv.15282. Epub 2018 Nov 13.

PMID:
30317678
6.

Knowledge and use of HIV pre-exposure prophylaxis among men who have sex with men in Berlin - A multicentre, cross-sectional survey.

Werner RN, Gaskins M, Ahrens J, Jessen H, Kutscha F, Mosdzen R, Osswald W, Sander D, Schellberg S, Schwabe K, Wünsche T, Dressler C, Sammons M, Nast A.

PLoS One. 2018 Sep 13;13(9):e0204067. doi: 10.1371/journal.pone.0204067. eCollection 2018.

7.

S3 Guideline for the treatment of psoriasis vulgaris, update - Short version part 2 - Special patient populations and treatment situations.

Nast A, Amelunxen L, Augustin M, Boehncke WH, Dressler C, Gaskins M, Härle P, Hoffstadt B, Klaus J, Koza J, Mrowietz U, Ockenfels HM, Philipp S, Reich K, Rosenbach T, Rzany B, Schlaeger M, Schmid-Ott G, Sebastian M, von Kiedrowski R, Weberschock T.

J Dtsch Dermatol Ges. 2018 Jun;16(6):806-813. doi: 10.1111/ddg.13538.

PMID:
29873906
8.

S3-Leitlinie zur Therapie der Psoriasis vulgaris Update - Kurzfassung Teil 2 - Besondere Patientengruppen und spezielle Behandlungssituationen.

Nast A, Amelunxen L, Augustin M, Boehncke WH, Dressler C, Gaskins M, Härle P, Hoffstadt B, Klaus J, Koza J, Mrowietz U, Ockenfels HM, Philipp S, Reich K, Rosenbach T, Rzany B, Schlaeger M, Schmid-Ott G, Sebastian M, von Kiedrowski R, Weberschock T.

J Dtsch Dermatol Ges. 2018 Jun;16(6):806-814. doi: 10.1111/ddg.13538_g.

PMID:
29873903
9.

S3-Leitlinie zur Therapie der Psoriasis vulgaris Update - Kurzfassung Teil 1 - Systemische Therapie.

Nast A, Amelunxen L, Augustin M, Boehncke WH, Dressler C, Gaskins M, Härle P, Hoffstadt B, Klaus J, Koza J, Mrowietz U, Ockenfels HM, Philipp S, Reich K, Rosenbach T, Rzany B, Schlaeger M, Schmid-Ott G, Sebastian M, von Kiedrowski R, Weberschock T.

J Dtsch Dermatol Ges. 2018 May;16(5):645-670. doi: 10.1111/ddg.13516_g. No abstract available.

PMID:
29750455
10.

S3 Guideline for the treatment of psoriasis vulgaris, update - Short version part 1 - Systemic treatment.

Nast A, Amelunxen L, Augustin M, Boehncke WH, Dressler C, Gaskins M, Härle P, Hoffstadt B, Klaus J, Koza J, Mrowietz U, Ockenfels HM, Philipp S, Reich K, Rosenbach T, Rzany B, Schlaeger M, Schmid-Ott G, Sebastian M, von Kiedrowski R, Weberschock T.

J Dtsch Dermatol Ges. 2018 May;16(5):645-669. doi: 10.1111/ddg.13516.

PMID:
29750443
11.

Methods Report: Update of the German S3 Guideline for the Treatment of Psoriasis vulgaris.

Gaskins M, Dressler C, Werner RN, Nast A.

J Dtsch Dermatol Ges. 2018 May;16(5). doi: 10.1111/ddg.13471. No abstract available.

PMID:
29750442
12.

Management of antithrombotic agents in dermatologic surgery before and after publication of the corresponding German evidence-based guideline.

Gaskins M, Dittmann M, Eisert L, Werner RN, Dressler C, Löser C, Nast A.

J Dtsch Dermatol Ges. 2018 Mar;16(3):297-305. doi: 10.1111/ddg.13459.

PMID:
29537161
13.

Umgang mit Antithrombotika bei Operationen an der Haut vor und nach Publikation der entsprechenden S3-Leitlinie.

Gaskins M, Dittmann M, Eisert L, Werner RN, Dressler C, Löser C, Nast A.

J Dtsch Dermatol Ges. 2018 Mar;16(3):297-306. doi: 10.1111/ddg.13459_g.

PMID:
29537158
14.

Adjuvant treatment of anogenital warts with systemic interferon: a systematic review and meta-analysis.

Westfechtel L, Werner RN, Dressler C, Gaskins M, Nast A.

Sex Transm Infect. 2018 Feb;94(1):21-29. doi: 10.1136/sextrans-2017-053150. Epub 2017 Aug 17. Review.

PMID:
28819018
15.

Breast Cancer Prognosis for Young Patients.

Owrang M, Copeland RL Jr, Ricks-Santi LJ, Gaskins M, Beyene D, Dewitty RL Jr, Kanaan YM.

In Vivo. 2017 Jul-Aug;31(4):661-668.

16.

Pathways to Hazardous Drinking Among Racially and Socioeconomically Diverse Lesbian Women: Sexual Minority Stress, Rumination, Social Isolation, and Drinking to Cope.

Lewis RJ, Mason TB, Winstead BA, Gaskins M, Irons LB.

Psychol Women Q. 2016;40(4):564-581. doi: 10.1177/0361684316662603. Epub 2016 Aug 26.

17.

International prevalence of indoor tanning: a systematic review and meta-analysis.

Wehner MR, Chren MM, Nameth D, Choudhry A, Gaskins M, Nead KT, Boscardin WJ, Linos E.

JAMA Dermatol. 2014 Apr;150(4):390-400. doi: 10.1001/jamadermatol.2013.6896. Review. Erratum in: JAMA Dermatol. 2014 May;150(5):577.

18.

Hungary health system review.

Gaal P, Szigeti S, Csere M, Gaskins M, Panteli D.

Health Syst Transit. 2011;13(5):1-266.

19.

Major challenges ahead for Hungarian healthcare.

Gaál P, Szigeti S, Panteli D, Gaskins M, van Ginneken E.

BMJ. 2011 Dec 7;343:d7657. doi: 10.1136/bmj.d7657. No abstract available.

PMID:
22162289
20.

A GIS approach to prioritizing habitat for restoration using neotropical migrant songbird criteria.

Holzmueller EJ, Gaskins MD, Mangun JC.

Environ Manage. 2011 Jul;48(1):150-7. doi: 10.1007/s00267-011-9660-1. Epub 2011 Mar 20.

PMID:
21424570
21.

Coronary stents and the uptake of new medical devices in the German system of inpatient reimbursement.

Henschke C, Baeumler M, Gaskins M, Busse R.

J Interv Cardiol. 2010 Dec;23(6):546-53. doi: 10.1111/j.1540-8183.2010.00592.x. Epub 2010 Aug 23.

PMID:
20735711
22.

Breast cancer risk assessments comparing Gail and CARE models in African-American women.

Adams-Campbell LL, Makambi KH, Frederick WA, Gaskins M, Dewitty RL, McCaskill-Stevens W.

Breast J. 2009 Sep-Oct;15 Suppl 1:S72-5. doi: 10.1111/j.1524-4741.2009.00824.x.

23.

A phase II trial of 17-allylamino-17-demethoxygeldanamycin in patients with hormone-refractory metastatic prostate cancer.

Heath EI, Hillman DW, Vaishampayan U, Sheng S, Sarkar F, Harper F, Gaskins M, Pitot HC, Tan W, Ivy SP, Pili R, Carducci MA, Erlichman C, Liu G.

Clin Cancer Res. 2008 Dec 1;14(23):7940-6. doi: 10.1158/1078-0432.CCR-08-0221.

24.

African American women with breast cancer and their spouses' perception of care received from physicians.

Morgan PD, Barnett K, Perdue B, Fogel J, Underwood SM, Gaskins M, Brown-Davis C.

ABNF J. 2006 Jan-Feb;17(1):32-7.

PMID:
16596898
25.

It's not the heat, it's the humidity: wet weather increases legionellosis risk in the greater Philadelphia metropolitan area.

Fisman DN, Lim S, Wellenius GA, Johnson C, Britz P, Gaskins M, Maher J, Mittleman MA, Spain CV, Haas CN, Newbern C.

J Infect Dis. 2005 Dec 15;192(12):2066-73. Epub 2005 Nov 11.

PMID:
16288369
26.

A phase II trial of 17-allylamino-17- demethoxygeldanamycin in patients with hormone-refractory metastatic prostate cancer.

Heath EI, Gaskins M, Pitot HC, Pili R, Tan W, Marschke R, Liu G, Hillman D, Sarkar F, Sheng S, Erlichman C, Ivy P.

Clin Prostate Cancer. 2005 Sep;4(2):138-41. No abstract available.

PMID:
16197617
27.

African American couples merging strengths to successfully cope with breast cancer.

Morgan PD, Fogel J, Rose L, Barnett K, Mock V, Davis BL, Gaskins M, Brown-Davis C.

Oncol Nurs Forum. 2005 Sep 1;32(5):979-87.

PMID:
16136196
28.

Enrollment of African Americans onto clinical treatment trials: study design barriers.

Adams-Campbell LL, Ahaghotu C, Gaskins M, Dawkins FW, Smoot D, Polk OD, Gooding R, DeWitty RL.

J Clin Oncol. 2004 Feb 15;22(4):730-4.

PMID:
14966098
29.

Floc Formation by Azospirillum lipoferum Grown on Poly-beta-Hydroxybutyrate.

Bleakley BH, Gaskins MH, Hubbell DH, Zam SG.

Appl Environ Microbiol. 1988 Dec;54(12):2986-95.

30.

POlygalacturonic acid transeliminase production by Azospirillum species.

Tien TM, Diem HG, Gaskins MH, Hubbell DH.

Can J Microbiol. 1981 Apr;27(4):426-31.

PMID:
7237287
31.

Association of azospirillum with grass roots.

Umali-Garcia M, Hubbell DH, Gaskins MH, Dazzo FB.

Appl Environ Microbiol. 1980 Jan;39(1):219-26.

32.
33.

Nitrogen Fixation in Grasses Inoculated with Spirillum lipoferum.

Smith RL, Bouton JH, Schank SC, Quesenberry KH, Tyler ME, Milam JR, Gaskins MH, Littell RC.

Science. 1976 Sep 10;193(4257):1003-5.

PMID:
17735702

Supplemental Content

Loading ...
Support Center